The effect of 0.05% atropine eye drops on the eye-related functions among adult myopes.

Phase 3

• Conditions: Progressive Mypoia; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12622001374752
• Lead Sponsor: nversity of New South Wales -UNSW

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-10-26
• Last Update Posted: 31 October 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

•Aged between 18-35 years .
•Have normal general and eye health.
•Have an optical prescription between -0.50 and -4.00D; with less than -1.50D of astigmatism.
•Have ‘normal’ vision, measuring 6/7.5 or better with correction (0,2 LogMar).
•Have a normal color vision.
•Have normal intraocular pressure (IOP).
•Willing to attend two study visits.

Exclusion Criteria

•Have used an atropine eye drop within 2 weeks prior to study enrolment.
•Have any eye diseases including inflammation, infection, or allergy.
•Have a history of allergic reactions to eye medications.
•Are at risk of glaucoma.
•Are currently using any eye medications or antidepression.
•Women who are pregnant, planning to become pregnant, or breastfeeding.

Study & Design

• Study Type: Interventional
• Study Design: Not specified